Rural–urban differentials in 30-day and 1-year mortality following first-ever heart failure hospitalisation in Western Australia: a population-based study using data linkage
Open Access
- 2 May 2014
- Vol. 4 (5), e004724
- https://doi.org/10.1136/bmjopen-2013-004724
Abstract
Objectives We examined differentials in short-term (30-day mortality) and 1-year mortality (in 30-day survivors) following index (first-ever) hospitalisation for heart failure (HF), between rural and metropolitan patients resident in Western Australia. Design A population-based cohort study. Setting Hospitalised patients in Western Australia, Australia. Participants Index patients aged 20–84 years with a first-ever hospitalisation for HF between 2000 and 2009 (with no prior admissions for HF in previous 10 years), identified using the Western Australia linked health data. Main outcome measures 30-day and 1-year all-cause mortality (in 30-day survivors) following index admission for HF. Results Of 17 379 index patients with HF identified, 25.9% (4499) were from rural areas. Rural patients were significantly younger at first HF hospitalisation than metropolitan patients. Aboriginal patients comprised 1.9% of metropolitan and 17.2% of rural patients. Despite some statistical differences, the prevalence of antecedents including ischaemic heart disease, hypertension, diabetes and chronic kidney disease was high (>20%) in both subpopulations. After adjusting for age only, patients from rural areas had a higher risk of 30-day death (OR 1.16 (95% CI 1.01 to 1.33)) and 1-year death in 30-day survivors (HR 1.11 (95% CI 1.01 to 1.23)). These relative risk estimates increased and remained significant after further progressive adjustments for Aboriginality, socioeconomic status, insurance status, emergency presentation, individual comorbidities and revascularisation with OR 1.25 (1.06 to 1.48) for 30-day mortality and HR 1.13 (1.02 to 1.27) for 1-year mortality. The addition of the weighted Charlson index to the 30-day model improved the ‘c’ statistic (under the receiver operating characteristic curve) from 0.656 (using a variation of administrative claims model) to 0.714. Conclusions Remoteness and variable access to healthcare can cause important disparities in health outcomes. Rural patients with HF in Western Australia have poorer risk-adjusted outcomes compared with metropolitan patients. This finding has important implications for chronic disease management and provision of health services in rural Australia.Keywords
This publication has 29 references indexed in Scilit:
- A comparison of Australian rural and metropolitan cardiovascular risk and mortality: the Greater Green Triangle and North West Adelaide population surveysBMJ Open, 2013
- Complex impact of remoteness on the incidence of myocardial infarction in Aboriginal and non‐Aboriginal people in Western AustraliaAustralian Journal of Rural Health, 2012
- Patterns of Care and Outcomes Differ for Urban Versus Rural Patients With Newly Diagnosed Heart Failure, Even in a Universal Healthcare SystemCirculation: Heart Failure, 2011
- Heart FailureCirculation: Heart Failure, 2010
- 'I don't know why they don't come': barriers to participation in cardiac rehabilitationAustralian Health Review, 2010
- Are the processes recommended by the NHMRC for improving Cardiac Rehabilitation (CR) for Aboriginal and Torres Strait Islander people being implemented?: an assessment of CR Services across Western AustraliaAustralia and New Zealand Health Policy, 2009
- A validation study: how effective is the Hospital Morbidity Data as a surveillance tool for heart failure in Western Australia?Australian and New Zealand Journal of Public Health, 2008
- A decade of data linkage in Western Australia: strategic design, applications and benefits of the WA data linkage systemAustralian Health Review, 2008
- Presentation adapting a clinical comorbidity index for use with ICD-9-CM administrative data: Differing perspectivesJournal of Clinical Epidemiology, 1993
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987